Publication | Open Access

Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial

Exploratory AnalysesOverall SurvivalMedicineCancer ManagementGynecologyRecurrent Endometrial CancerCancer TreatmentOncologyRadiation OncologyGynecology Oncology